SHOBHIT NEGI: Open Payments
NPI 1629051040 · MOUNT AIRY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 6 payments from 6 companies in 2025. Trend: 2023 $331 · 2024 $745 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $33 |
| ABBVIE INC. | 1 | $25 |
| Almatica Pharma LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| TMS NeuroHealth Centers Inc. | 1 | $11 |
Products named: INGREZZA, VRAYLAR, LOREEV XR, AUSTEDO XR, TRINTELLIX, TMS NeuroHealth Centers Inc..
Industry payments across MD — which companies pay providers there.
